BJP’s win is the victory of democracy: B S Yeddyurappa

Bengaluru, Jan 11: Scholar and writer M Chidanadamurthy passed away at a private hospital here on Saturday.

He was 88 and is survived by wife, son and daughter.
He was a well-known scholar in Karnataka specialising in the history of Kannada language and ancient Karnataka.

He was also known for his campaign to conserve the monuments Hampi and to secure classical language status to Kannada Language. Murthy has also articulated that uniform civil code and an anti-conversion law must be enacted by the Government in India.

Murthy was the head of the department of Kannada Bangalore University. He was also associated with Kannada Shakti Kendra. As a historian most of Murthy's work has focused on scientific study of the Kannada Inscriptions.

He has attempted to contextualise inscriptions in their socio cultural setup. He has produced many books on the history of Kannada language and Karnataka. He has guided many research students.

Murthy was recipient of Rajayothsava, Sathiya Academy Award , Papama award and Alava’s Nudisiri award.
His mortal remains were kept at his residence for his fellow mates and relatives.

Several dignatories like B S Yediyurappa, S L Bhyrappa, S Suresh Kumar, V Somanna expressed their condolences to the veteran's death.

The final rituals will be held on Sunday with state honour.

New Delhi, Jun 11: The Department of Pharmaceuticals has given its nod for lifting of ban on the export of hydroxychloroquine, Union Minister D V Sadananda Gowda said on Wednesday.

India had banned export of hydroxychloroquine on March 25, with some exceptions, amid views in some quarters that the drug could be used to fight COVID-19. On April 4, it completely banned the exports without any exception.

"Department of Pharmaceuticals has approved the lifting of ban on export of Hydroxychloroquine API as well as formulations. Manufacturers except SEZ/EOU Units have to supply 20 per cent production in the domestic market," the minister of chemicals and fertilisers said in a tweet.

The Directorate General of Foreign Trade (DGFT) has been asked to issue formal notification in this regard, he added.

In another tweet, Gowda said he held discussions with representatives of pharma companies along with some of his ministerial colleagues on the challenges being faced by the industry and on the roadmap to boost exports.

"Had detailed discussion with representatives of pharma companies & association, stakeholder Ministries along with Hon Ministers @piyushGoyal  ji, @HardeepSPuri  ji, & @MansukhMandviya  ji on entire gamut of challenges faced by the industry as well as strategies to boost pharma export," Gowda tweeted.

India exported hydroxychloroquine API (active pharmaceutical ingredient) worth USD 1.22 billion in April-January 2019-20.

During the same period, exports of formulations made from hydroxychloroquine was at USD 5.50 billion.

Thiruvananthapuram, Feb 17: Out of the total 418 samples of suspect coronavirus cases sent for testing to National Institute of Virology from Kerala, 405 have come out as negative, while the results for the rest, barring three, are awaited.

"Out of three persons in whom the disease was confirmed, two persons have been discharged. One person is stable and the repeat sample results are awaited," according to a release by the Health and Family Welfare Department of the Kerala government.

The release added that till Sunday a total of 2,276 people have been placed under surveillance, "out of which 2262 are under home isolation and 14 are admitted in designated isolation facilities."

The health condition of all symptomatic people under isolation is stable, according to the release.

The release added that the Ministry of Health and Family Welfare (Centre) has informed the Kerala government that 115 people belonging to Kerala are currently in quarantine in two camps in Delhi.

These 115 people have been tested and found negative for coronavirus and they will be allowed to travel back to Kerala on Monday evening.

The people have been requested to remain in home isolation upon their return.